Tobinco’s Lufart Wins Prestigious Award At Ghana Int’l Products Event

In a momentous event that highlights the strides made by the Ghanaian pharmaceutical industry, Tobinco Pharmaceuticals’ flagship product, Lufart, has been awarded the prestigious Best Pharmaceutical Product at the Ghana International Products Event (GIPE) held in Accra. The Ghana International Products Event, known for showcasing innovations and excellence across various industries, attracted top-tier companies and professionals from around the globe. The competition was fierce, with numerous entries vying for the coveted awards in different categories. However, it was Lufart, Tobinco’s leading antimalarial medication, that stood out and claimed the top honor in the pharmaceutical sector.

Lufart, developed by Tobinco Pharmaceuticals, has been a game-changer in the fight against malaria. With its unique formulation and proven efficacy, Lufart has significantly contributed to reducing malaria-related morbidity and mortality in Ghana and beyond. The product's success is a testament to the company’s commitment to innovation, quality, and public health. In his acceptance speech, Mr. Samuel Amo Tobbin, the Executive Chairman of Tobinco Pharmaceuticals, expressed his gratitude for the recognition and dedicated the award to the hardworking team at Tobinco. He emphasized the importance of continuous innovation in the pharmaceutical industry and reiterated Tobinco’s commitment to providing affordable and effective medications to the people of Ghana and the entire African continent.

“We are deeply honored to receive this prestigious award,” said Mr. Tobbin. “This recognition is a testament to the dedication and hard work of our team and the trust placed in us by healthcare professionals and patients. We will continue to invest in research and development to bring more life-saving products to the market.”

The award has been seen as a significant achievement for Tobinco Pharmaceuticals, reinforcing its position as a leader in the Ghanaian pharmaceutical industry. It also highlights the potential of local pharmaceutical companies to compete on an international level, driving forward the country's aspirations for healthcare excellence.

Industry experts have lauded the win as a milestone for the Ghanaian pharmaceutical sector. Dr. Ama Benneh-Akwasi, a renowned public health specialist, commented on the impact of such recognitions. “Awards like these not only validate the hard work of our local pharmaceutical companies but also inspire other players in the industry to strive for excellence. This is a positive development for Ghana’s healthcare landscape.”

The Ghana International Products Event, with its focus on innovation and excellence, continues to be a significant platform for showcasing the best products and services across various sectors. Tobinco Pharmaceuticals’ win with Lufart serves as an inspiration and a benchmark for future participants. As the event concluded, it was clear that the success of Lufart at GIPE has set a new standard in the pharmaceutical industry, emphasizing the importance of quality, innovation, and dedication in improving public health outcomes. Tobinco Pharmaceuticals is poised to continue its journey of excellence, contributing significantly to the healthcare sector in Ghana and beyond.